EX-23.1 4 adms10k2018ex231.htm EXHIBIT 23.1 Exhibit


Exhibit 23.1
 
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-214409) and Form S‑8 (Nos. 333-223147, 333-216313, 333-210255, 333-202467 and 333-195384) of Adamas Pharmaceuticals, Inc. of our report dated March 4, 2019 relating to the financial statements, which appears in this Form 10-K.
 
/s/ PricewaterhouseCoopers LLP 
San Jose, California
March 4, 2019